stella
beta
Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients — Stella
Recruiting
Back to Critical Illness trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(4 sites)
Canada
St Joseph's Healthcare Hamilton, Hamilton, Ontario
Kingston Health Sciences Centre, Kingston, Ontario
The Ottawa Hospital - General Campus, Ottawa, Ontario
The Ottawa Hospital - Civic Campus, Ottawa, Ontario
View full record on ClinicalTrials.gov